A retrospective review of the use of thromboprophylaxis in patients who subsequently developed a venous thromboembolism after discharge from hospital

New Zealand Medical Journal

Volumn 123, Issue 1309, 2010, Pages 37-49

  Wiseman, Diane N ^a   Harrison, Jeff ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ENOXAPARIN; HEPARIN; WARFARIN;

ADULT; AGED; ARTICLE; FEMALE; HOSPITAL DISCHARGE; HOSPITAL READMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; NEW ZEALAND; PATIENT IDENTIFICATION; PRACTICE GUIDELINE; PRESCRIPTION; RISK ASSESSMENT; RISK FACTOR; SURGICAL PATIENT; THROMBOSIS PREVENTION; VENOUS THROMBOEMBOLISM;

ADULT; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; CLINICAL AUDIT; DRUG UTILIZATION; ENOXAPARIN; FEMALE; GUIDELINE ADHERENCE; HEPARIN; HUMANS; MALE; MIDDLE AGED; NEW ZEALAND; PATIENT DISCHARGE; PATIENT READMISSION; PRACTICE GUIDELINES AS TOPIC; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; STOCKINGS, COMPRESSION; SURGICAL PROCEDURES, OPERATIVE; VENOUS THROMBOEMBOLISM; WARFARIN;

EID: 77149140178     PISSN: None     EISSN: 11758716     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Fitzmaurice DA, Murray E. Thromboprophylaxis for adults in hospital. BMJ. 2007 May 19;334(7602):1017-8.
2. Anderson FA Jr, Spencer FA. Risk Factors for Venous Thromboembolism. Circulation. 2003 Jun 17;107(23 Suppl 1):I9-16.
3. Geerts WH, Pineo GF, Heit JA, et al. Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004 Sep;126(3 Suppl):338S-400S.
4. Cayley WE Jr. Preventing deep vein thrombosis in hospital inpatients. BMJ. 2007 Jul 21;335(7611):147-51.
5. Samama MM, Cohen AT, Darmon JY, et al. A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin Study Group. N Engl J Med. 1999 Sep 9;341(11):793-800.
6. Wein L, Wein S, Haas SJ, et al. Pharmacological venous thromboembolism prophylaxis in hospitalised medical patients: a meta-analysis of randomized controlled trials. Arch Intern Med. 2007 Jul 23;167(14):1476-86.
7. Collins R, Scrimgeour A, Yusuf S, Peto R. Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. Overview of results of randomized trials in general, orthopedic, and urologic surgery. N Engl J Med. 1988 May 5;318(18):1162-73.
8. Mismetti P, Laporte S, Darmon JY, et al. Meta-analysis of low molecular weight heparin in the prevention of venous thromboembolism in general surgery. Br J Surg. 2001 Jul;88(7):913-30.
9. Yu HT, Dylan ML, Lin J, Dubois RW. Hospitals' compliance with prophylaxis guidelines for venous thromboembolism. Am J Health Syst Pharm. 2007 Jan 1;64(1):69-76.
10. Amin A, Stemkowski S, Lin J, Yang G. Thromboprophylaxis rates in US medical centers: success or failure? J Thromb Haemost. 2007 Aug;5(8):1610-6.
11. Spencer FA, Lessard D, Emery C, et al. Venous thromboembolism in the outpatient setting. Arch Intern Med. 2007 Jul 23;167(14):1471-5.
12. National Working Party on the Management and Prevention of Venous Thrombosis. Prevention of venous thrombosis. Best practice guidelines for Australia and New Zealand. 4th edn. Health Education and Management International, 2007.
13. Joint Formulary Committee. British National Formulary. 53 ed. London: British Medical Association and Royal Pharmaceutical Society of Great Britain; 2007.
14. MIMS New Ethicals Issue 6. Jan-Jun 2007. CMPMedica.
15. Cunningham MS, White B, O'Donnell J. Prevention and management of venous thromboembolism in people with cancer: a review of the evidence. Clin Oncol (R Coll Radiol). 2006 Mar;18(2):145-51.
16. Prandoni P, Falanga A, Piccioli A. Cancer and venous thromboembolism. Lancet Oncol. 2005 Jun;6(6):401-10.
17. Alikhan R, Cohen AT, Combe S, et al. Risk factors for venous thromboembolism in hospitalised patients with acute medical illness: analysis of the MEDENOX Study. Arch Intern Med. 2004 May 10;164(9):963-8
18. Samama MM. An epidemiologic study of risk factors for deep vein thrombosis in medical outpatients: the Sirius study. Arch Intern Med. 2000 Dec 11-25;160(22): 3415-20.
19. White RH. The epidemiology of venous thromboembolism. Circulation. 2003 Jun 17;107(23 Suppl 1):I4-8.
20. Arnold DM, Kahn SR, Shrier I. Missed opportunities for prevention of venous thromboembolism: an evaluation of the use of thromboprophylaxis guidelines. Chest. 2001 Dec;120(6):1964-71.
21. Scottish Intercollegiate Guidelines Network. (2002) Prophylaxis of venous thromboembolism. Edinburgh: Scottish Intercollegiate Guidelines Network. (Guideline Ref ID: SIGN2002)
22. Kearon C. Duration of venous thromboembolism prophylaxis after surgery. Chest. 2003 Dec;124(6 Suppl):386S-392S
23. Cohen AT, Tapson VF, Bergmann JF, et al. Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study. Lancet. 2008 Feb 2;371(9610):387-94.
24. Kakkar AK, Davidson BL, Haas SK; Investigators Against Thromboembolism (INATE) Core Group. Compliance with recommended prophylaxis for venous thromboembolism: improving the use and rate of uptake of clinical practice guidelines. J Thromb Haemost. 2004 Feb;2(2):221-7.
25. Cohen AT, Alikhan R, Arcelus JI, et al. Assessment of venous thromboembolism risk and the benefits of thromboprophylaxis in medical patients. Thromb Haemost. 2005 Oct;94(4):750-9.
26. Schiff RL, Kahn SR, Shrier I, et al. Identifying orthopedic patients at high risk for venous thromboembolism despite thromboprophylaxis. Chest. 2005 Nov;128(5): 3364-71.